Niagen Bioscience (NAGE) Assets (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Assets data on file, last reported at $114.3 million in Q1 2026.

• On a quarterly basis, Assets rose 40.56% year-over-year to $114.3 million in Q1 2026; TTM through Mar 2026 was $114.3 million, a 40.56% increase from a year earlier, with the FY2025 full-year figure at $106.4 million, up 55.84% from the prior year.
• Assets for Q1 2026 stood at $114.3 million, up from $106.4 million in the prior quarter.
• Over the last five years, Assets for NAGE reached as high as $114.3 million in Q1 2026 and fell as low as $45.7 million in Q3 2022.
• Historically, Assets has averaged $67.0 million across 5 years, with a median of $54.1 million in 2024.
• Across the five-year window, Assets decreased 29.2% in 2022 and soared 73.63% in 2025, its largest moves.
• Year by year, Assets stood at $54.1 million in 2022, then rose by 1.68% to $55.0 million in 2023, then grew by 24.22% to $68.3 million in 2024, then soared by 55.84% to $106.4 million in 2025, then advanced by 7.45% to $114.3 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $114.3 million in Q1 2026, $106.4 million in Q4 2025, and $98.1 million in Q3 2025.